BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 9, 2009
View Archived Issues
Weight loss seen in one-year studies of velneperit in obese subjects
Read More
AMPA receptor potentiator PF-4778574 safe and active in preclinical models of cognition
Read More
NOP receptor agonist SCH-655842 exhibits anxiolytic activity in preclinical models
Read More
SUVN-623 shows promising activity in animal models of cognition
Read More
Nicotinic alpha4beta2 receptor modulator A-969933 alters the stimulant effects of nicotine
Read More
Results reported for phase I clinical trial of new slow-release metadoxine
Read More
Dong-A PharmTech starts phase III trials of udenafil in men with erectile dysfunction
Read More
FDA grants orphan drug designation to Sunesis' voreloxin for acute myeloid leukemia
Read More
FDA advisory committee to review Theratechnologies' NDA for tesamorelin
Read More
Ligand Pharmaceuticals and Pfizer extend research collaboration for JAK3
Read More
InterMune submits NDA to FDA for pirfenidone in idiopathic pulmonary fibrosis
Read More
Immunovaccine and Canadian military collaborate to develop anthrax vaccine
Read More
FDA approves labeling update for Reyataz to include 96-week CASTLE data
Read More
Dipeptidyl peptidase IV inhibitors claimed by Taiwanese scientists as antidiabetics
Read More
Helix completes enrollment in phase II topical interferon alpha-2b trial
Read More
Raf kinase inhibitors disclosed by Wyeth for the treatment of cancer
Read More
BMS describes serine protease inhibitors for treating thromboembolic disorders
Read More
ERYtech Pharma starts pivotal trial of Graspa in acute lymphoblastic leukemia
Read More
FDA approves Gloucester's Istodax for cutaneous T-cell lymphoma
Read More
FDA approves Pennsaid topical solution for osteoarthritis of the knee
Read More
Theravance and Astellas Pharma launch telavancin in the U.S.
Read More
Novexel initiates phase II clinical trial of NXL-103 in bacterial skin infections
Read More
Shire launches Intuniv in the U.S. for ADHD in children and adolescents
Read More
Phase I study finds potential for rontalizumab in systemic lupus erythematosus
Read More
AIDS Vaccine meeting snapshots: Phase I and II trials of candidate vaccines
Read More
